Brett Kleger, Chief Commercial Officer, DrugDev told Outsourcing-Pharma.com the technology combines several solutions into “a single suite with one interface that spans each functional area in the lifecycle of an individual clinical trial or an entire program – planning, startup, payments and trial conduct.”
All of these actives are tied to the DrugDev Profiles System, which uses the DrugDev Golden Number – the universal data standard for site facilities and personnel used by the TransCelerate Investigator Registry, the Investigator Databank and CROs – which is used to match master site facilities and personnel information.
Through the partnership with the Association of Clinical Research Professionals (ACRP), sponsors and CROs using DrugDev Spark for study planning and site identification will have access to investigator site and personal profiles.
ACRP is the first organization to partner with DrugDev in this capacity.
“We need to transform the way trials are run and can do it if we focus on these three imperatives – industry-wide collaboration, data standardization, and technology,” said Kleger.
“This is the only way to fundamentally change the economics of clinical trials, so sponsors and CROs can do more trials for the same or reduced budget – meaning more potential drug candidates are tested, and more beneficial treatments are available to improve the lives of patients and families worldwide,” he added.
DrugDev Spark was initially introduced to 100 clinical trial leaders from sponsor, CRO and site organizations at the company’s annual User Summit last fall before being unveiled to the industry at the SCOPE Summit in January of this year.
“Customers appreciate the flexibility of the system (which allows them to use one or two solutions, the whole suite either or anything in between) and the potential it has to significantly improve the site experience by consolidating/eliminating system logins,” said Kleger.